We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
-14.68%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$3.34B
AUM Growth
-$500M
Cap. Flow
+$164M
Cap. Flow %
4.9%
Top 10 Hldgs %
9.82%
Holding
1,404
New
145
Increased
727
Reduced
365
Closed
141

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$14M
2
PG icon
Procter & Gamble
PG
+$11.3M
3
KR icon
Kroger
KR
+$10.6M
4
NOC icon
Northrop Grumman
NOC
+$8.11M
5
BIIB icon
Biogen
BIIB
+$8.03M

Sector Composition

Rank Sector Weight
1 Technology 23.57%
2 Energy 13.98%
3 Healthcare 13.42%
4 Industrials 10.8%
5 Consumer Discretionary 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XHR
1076
Xenia Hotels & Resorts
XHR
$1.74B
$244K 0.01%
16,795
-183
-1% -$3.26K
DVN icon
1077
Devon Energy
DVN
$49.9B
$242K 0.01%
4,480
+430
+11% +$28.1K
NTR icon
1078
Nutrien
NTR
$31.6B
$241K 0.01%
+3,041
New +$295K
GNTX icon
1079
Gentex
GNTX
$5.02B
$240K 0.01%
8,656
+921
+12% +$26.8K
VEEV icon
1080
Veeva Systems
VEEV
$38.1B
$240K 0.01%
1,218
+130
+12% +$23.9K
ZBH icon
1081
Zimmer Biomet
ZBH
$18.7B
$236K 0.01%
2,265
-4,607
-67% -$547K
BF.B icon
1082
Brown-Forman Class B
BF.B
$12.9B
$235K 0.01%
3,358
-5,741
-63% -$385K
NUS icon
1083
Nu Skin
NUS
$250M
$235K 0.01%
5,439
-102
-2% -$4.68K
VICR icon
1084
Vicor
VICR
$9.63B
$235K 0.01%
4,300
+68
+2% +$4.22K
HBAN icon
1085
Huntington Bancshares
HBAN
$35.6B
$232K 0.01%
19,672
-970
-5% -$12.9K
GIL icon
1086
Gildan
GIL
$10.6B
$229K 0.01%
+7,979
New +$255K
TRIP icon
1087
TripAdvisor
TRIP
$1.26B
$228K 0.01%
12,844
-3,322
-21% -$78.8K
UNIT
1088
Uniti Group
UNIT
$2.28B
$227K 0.01%
24,062
-3,395
-12% -$39.3K
APD icon
1089
Air Products & Chemicals
APD
$68.6B
$226K 0.01%
959
-2,406
-72% -$585K
BLDP
1090
Ballard Power Systems
BLDP
$769M
$226K 0.01%
36,185
+86
+0.2% +$688
EWBC icon
1091
East-West Bancorp
EWBC
$18.1B
$226K 0.01%
3,508
+201
+6% +$14.4K
ONT
1092
Onterris Inc
ONT
$546M
$226K 0.01%
6,682
-192
-3% -$8.03K
SOL
1093
DELISTED
Emeren Group
SOL
$226K 0.01%
47,683
+7,007
+17% +$34.1K
STE icon
1094
Steris
STE
$23.3B
$226K 0.01%
1,098
-2,054
-65% -$463K
AFRM icon
1095
Affirm
AFRM
$25.3B
$225K 0.01%
12,453
+1,793
+17% +$48.8K
SMCI icon
1096
Super Micro Computer
SMCI
$20.4B
$225K 0.01%
55,830
-50,400
-47% -$230K
MRNA icon
1097
Moderna
MRNA
$23.9B
$223K 0.01%
1,606
-14,725
-90% -$2.1M
ACM icon
1098
Aecom
ACM
$9.42B
$222K 0.01%
3,404
+430
+14% +$30.1K
NTNX icon
1099
Nutanix
NTNX
$17.4B
$222K 0.01%
15,226
+3,599
+31% +$75K
GFI icon
1100
Gold Fields
GFI
$36.8B
$220K 0.01%
24,530
+8,612
+54% +$103K

Similar funds

Vident Investment Advisory's Q2 2022 Portfolio in Review

As of Q2 2022, Vident Investment Advisory held 1,404 positions worth $3.34B, down 13% from $3.84B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Vident Investment Advisory deployed $164M of net new capital in Q2 2022, opening 145 new positions and adding to 727 existing holdings. Its largest new stake was Samsara: 1,361,007 shares worth $15.2M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Walmart Inc, an estimated $14M trimmed.

  • Vident Investment Advisory's largest Q2 2022 buy was Samsara: 1,361,007 shares worth $15.2M.
  • Vident Investment Advisory added most to Meta Platforms (Facebook) in Q2 2022, an estimated $13.4M increase.
  • Vident Investment Advisory's biggest Q2 2022 reduction was Walmart Inc, cutting an estimated $14M.
  • Vident Investment Advisory fully exited Cerner Corp in Q2 2022, selling an estimated $7.01M.
  • Vident Investment Advisory's ten largest holdings make up 9.8% of its $3.34B portfolio in Q2 2022.
  • Vident Investment Advisory opened 145 new positions and closed 141 in Q2 2022.
  • Vident Investment Advisory's portfolio value fell 13% quarter-over-quarter to $3.34B.

Based on Vident Investment Advisory's 13F filing for Q2 2022, filed 15 Aug 2022.